BOLD-100's Broad Potential Featured at the AACR Annual Meeting 2022
/PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company, announced that will be presenting research supporting the use of BOLD-100 in...
Source: prnewswire.com